Wire Stories
-
417Inaugural Chuxiong Fashion Week Highlights the Ethnic Costumes Culture in Yunnan
CHUXIONG, China–(BUSINESS WIRE)–The First Chuxiong Fashion Week Gala was held in Chuxiong Grand Theater in Chuxiong Yi Autonomous Prefecture, Yunnan Province of...
-
442Empowering Moms Throughout 2023: The Year of Momcozy’s Dedication
NEW YORK–(BUSINESS WIRE)–The endeavors of Momcozy, exemplified by initiatives such as the “Just Be a Cozy Mom” campaign and the Breastfeeding Support...
-
457Rare Element Resources Announces Plans for Management Change
LITTLETON, Colo.–(BUSINESS WIRE)–Rare Element Resources Ltd. (the “Company” or “RER”) (OTCQB: REEMF) announces that its President and Chief Executive Officer Brent Berg,...
-
424Global Next Generation Advanced Batteries Strategic Industry Report 2024: Market to Reach $16.2 Billion by 2030 – Lithium Ion (Li-Ion) Battery Limitations to Present Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Next Generation Advanced Batteries – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. Global Next Generation Advanced Batteries...
-
321AMTD IDEA Awarded “Best Financial Services” Recognition
PARIS & NEW YORK & SINGAPORE–(BUSINESS WIRE)–AMTD IDEA Group (NYSE: AMTD; SGX: HKB) (“AMTD IDEA” or the “Company”) is pleased to announce...
-
416FDA Accepts for Review BLA for DMB-3115 of Dong-A ST, a Proposed Biosimilar to Stelara® (Ustekinumab)
– Following EMA, FDA accepted BLA for DMB-3115 SEOUL, South Korea–(BUSINESS WIRE)–#AccordBiopharma—Dong-A ST (President/CEO Min-young Kim, KRX:170900) announced that Accord BioPharma, Inc.,...
-
331Omni Design Technologies Unveils Next-Gen LiDAR Solutions with Swift™ Data Converters
SAN JOSE, Calif.–(BUSINESS WIRE)–#ADAS—Omni Design Technologies, a leading provider of high-performance, low-power mixed-signal intellectual property (IP), today announced their expanded silicon IP...
-
360Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
Enrolled first PH-ILD patient in the open-label ASCENT study of YUTREPIA Confirmed with FDA that a single pivotal efficacy trial with L606...
-
726Delta-Fly Pharma Inc.: Update on the R&D status of DFP-10917 and DFP-14927, a novel PEG Drug Conjugate, in the patients with R/R AML
TOKUSHIMA, Japan–(BUSINESS WIRE)–Following the previous information on June 30th in 2023, we are excited to share our latest development status. A Phase...
-
430New Year’s Eve Countdown Event “HAPPY NEW YEAR TOKYO” Was Held for the First Time at the Tokyo Metropolitan Government Building!
Projection Mapping Light Show and Stage Event were Performed TOKYO–(BUSINESS WIRE)–#HAPPYNEWYEARTOKYO–In order to see off 2023 and share the charms of Tokyo...
